Researchers have published preliminary results of a first-in-human clinical trial for dry age-related macular degeneration (AMD). Four patients received implants consisting of human embryonic stem cell-derived retinal pigment epithelium (RPE), which support light-sensitive photoreceptor cells critical to vision.